#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2114722	F	PubChem BioAssay. Cell Proliferation Assay against the HBL1 Cell Line. (Class of assay: confirmatory)		235	ALA1201862	assay format	PubChem BioAssays
2.	ALA2114730	F	PubChem BioAssay. Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 16 hrs). (Class of assay: confirmatory)		270	ALA1201862	assay format	PubChem BioAssays
3.	ALA2114770	F	PubChem BioAssay. qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway. (Class of assay: confirmatory)		267	ALA1201862	assay format	PubChem BioAssays
4.	ALA2114779	F	PubChem BioAssay. Cytotoxicity counterscreen for NFkB agonists and antagonists. (Class of assay: confirmatory)		224	ALA1201862	assay format	PubChem BioAssays
5.	ALA2114900	F	PubChem BioAssay. Cell Proliferation Assay against the TMD8 Cell Line. (Class of assay: confirmatory)		186	ALA1201862	assay format	PubChem BioAssays
6.	ALA2363475	F	SANGER: Inhibition of human NCI-H1563 cell growth in a cell viability assay.	Homo sapiens	98	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
7.	ALA2363476	F	SANGER: Inhibition of human NCI-H1573 cell growth in a cell viability assay.	Homo sapiens	85	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
8.	ALA2363477	F	SANGER: Inhibition of human NCI-H1581 cell growth in a cell viability assay.	Homo sapiens	137	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
9.	ALA2363479	F	SANGER: Inhibition of human NCI-H1623 cell growth in a cell viability assay.	Homo sapiens	98	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
10.	ALA2363480	F	SANGER: Inhibition of human NCI-H1648 cell growth in a cell viability assay.	Homo sapiens	133	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
11.	ALA2363481	F	SANGER: Inhibition of human NCI-H1650 cell growth in a cell viability assay.	Homo sapiens	134	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
12.	ALA2363482	F	SANGER: Inhibition of human NCI-H1651 cell growth in a cell viability assay.	Homo sapiens	98	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
13.	ALA2363483	F	SANGER: Inhibition of human NCI-H1666 cell growth in a cell viability assay.	Homo sapiens	58	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
14.	ALA2363484	F	SANGER: Inhibition of human NCI-H1693 cell growth in a cell viability assay.	Homo sapiens	98	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
15.	ALA2363488	F	SANGER: Inhibition of human NCI-H1755 cell growth in a cell viability assay.	Homo sapiens	98	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
16.	ALA2363489	F	SANGER: Inhibition of human NCI-H1770 cell growth in a cell viability assay.	Homo sapiens	129	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
17.	ALA2363490	F	SANGER: Inhibition of human NCI-H1792 cell growth in a cell viability assay.	Homo sapiens	98	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
18.	ALA2363491	F	SANGER: Inhibition of human NCI-H1793 cell growth in a cell viability assay.	Homo sapiens	98	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
19.	ALA2363492	F	SANGER: Inhibition of human NCI-H1838 cell growth in a cell viability assay.	Homo sapiens	134	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
20.	ALA2363497	F	SANGER: Inhibition of human NCI-H1993 cell growth in a cell viability assay.	Homo sapiens	98	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer